Physical properties of the aorta and cardiac hypertrophy in essential hypertension

B M Pannier1, G M London, J L Cuche

  • 1Department of Internal Medicine, Broussais Hospital, Paris, France.

European Heart Journal
|November 1, 1990
PubMed

Insights

Hypertension increases heart load through higher vascular resistance and reduced aortic compliance. This decreased aortic elasticity is linked to increased cardiac mass, potentially worsening hypertension effects.

Area of Science:

  • Cardiology
  • Vascular Physiology
  • Hypertension Research

Background:

  • Hypertension significantly increases the heart's workload.
  • This load is attributed to elevated peripheral vascular resistance and diminished aortic compliance.
  • Reduced aortic elasticity is a key factor in cardiovascular strain.

Purpose of the Study:

  • To investigate the relationship between aortic compliance and cardiac mass in hypertensive patients.
  • To understand how decreased aortic compliance contributes to cardiac hypertrophy.
  • To explore the implications for hypertension management and epidemiology.

Main Methods:

  • Utilized non-invasive clinical studies.
  • Measured pulse wave velocity to assess arterial stiffness.
  • Analyzed systolic-diastolic variations in aortic arch diameter.

Main Results:

  • A strong correlation was found between decreased aortic compliance and increased cardiac mass.
  • This relationship persisted even after adjusting for blood pressure levels.
  • Findings suggest reduced aortic compliance exacerbates systolic pressure and end-systolic stress.

Conclusions:

  • Decreased aortic compliance is a significant contributor to cardiac hypertrophy in hypertension.
  • This mechanism may have substantial implications for understanding hypertension's epidemiology and treatment.
  • Targeting aortic compliance could be crucial for managing hypertensive heart disease.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...